The 12 references without contexts in paper A. Sizikov E., V. Senyukov V., V. Kozhevnikov S., L. Konenkova P., E. Zonova V., M. Korolev A., N. Pronkina V., O. Herzog A., N. Pronkina V., E. Menyaeva V., E. Evsyukova V., V. Kozlov A., А. Сизиков Э., В. Сенюков В., В. Кожевников С., Л. Коненкова П., Е. Зонова В., М. Королев А., Н. Пронкина В., О. Герцог А., Н. Пронкина В., Е. Меняева В., Е. Евсюкова В., В. Козлов А. (2014) “КРАТКИЕ СООБЩЕНИЯ КЛИНИКО-ИММУНОЛОГИЧЕСКАЯ ХАРАКТЕРИСТИКА БОЛЬНЫХ РЕВМАТОИДНЫМ АРТРИТОМ С АНЕМИЕЙ // THE IMMUNOLOGICAL CHARACTERISTIC OF RA PATIENTS WITH ANAEMIA” / spz:neicon:mimmun:y:2005:i:6:p:593-600

1
Беневоленская Л.И., Бржезовский М.М. Эпи$ демиология ревматических болезней. $ М.: Медици$ на, 1988. $ 115 с.
(check this in PDF content)
4
Кожевников В.С., Набиуллин Р.Р., Богида$ ев С.В., Лозовой В.П. Способ оценки клеточных иммунных реакций in vitro // АС No 1575711, 1990
(check this in PDF content)
25
Davis L.S., Cush J.J., Schulze$Koops H., Lipsky P.E. Rheumatoid synovial CD4+ T cells exhibit a re$ duced capacity to differentiate into IL$4$producing T$ helper$2 effector cells. Arthritis Res 2001;3:54$64.
(check this in PDF content)
28
Emery P., Gentry K.C., Mackay I.R., Muirden K.D., and Rowley M. Deficiency of the suppressor in$ ducer subset of T lymphocytes in rheumatoid arthritis. Arthritis Rheum, August 1, 1987; 30(8): 849$56.
(check this in PDF content)
31
Janossy G., Panayi G., Duke O., Bofill M., Poulter L.W., Goldstein G. Rheumatoid arthritis: a dis$ ease of T$lymphocyte / macrophages immunoregula$ tion. Lancet 1981: i: 839$841.
(check this in PDF content)
32
Keystone E.C, Poplonski L., Miller R.G., Gorc$ zynski R., Gladman D., Snow K. Reactivity of T$cell from patients with rheumatoid arthritis to anti$CD3 antibody. Clin Immunol Immunopathol, September 1, 1988; 48(3): 325 $ 37.
(check this in PDF content)
35
Maino C.V., Picker L.J. Identification of func$ tional subsets by flow cytometry: intracellular detec$ tion of cytokine expression. Cytometry 34:207$215, 1995.
(check this in PDF content)
39
Pincus T., Callahan L.F. Taking mortality in rheumatoid arthritis seriously $ predictive markers, so$ cioeconomic status and comorbidity. J Rheumatol 1986;13:841$5.
(check this in PDF content)
42
Scott D.L., Symmons D.P., Coulton B.L., Pop$ ert A.J. Long$term outcome of treating rheumatoid arthritis: results after 20 years. Lancet 1987;1:1108$ 11.
(check this in PDF content)
43
Shaw T., Quan J., Totoritis M.C. B cell thera$ py for rheumatoid arthritis: the rituximab (anti$ CD20) experience. Ann Rheum Dis 2003;62(Suppl II): 55$59.
(check this in PDF content)
44
Schuerwegh A.J., De Clerck L.S., De Schutter L., Bridts C.H., Verbruggen A., Stevens W.J. Flow cytometric detection of type 1 (IL$2, INF$gamma) and Type 2 (IL$4, IL$5) cytokines in T$helper and T$sup$ pressor/cytotoxic cells in rheumatoid arthritis, aller$ gic asthma and atopic dermatitis. Cytokine 1999;11:783$88.
(check this in PDF content)
46
Graaff W.L., Prins A.P.A., Niers T.M.H., Dijkmans B.A.C., van Lier R.A.W. Quantitation of in$ terferon gamma$ and interleukin$4$producing T cells in synovial fluid and peripheral blood of arthritis pa$ tients. Rheumatology 1999;38:214$20.
(check this in PDF content)